Margaret (Maggie) Lowenstein, MD, MPhil, MSHP is a general internist, addiction medicine physician, and an Assistant Professor of Medicine at the Perelman School of Medicine. Dr. Lowenstein’s research focuses on novel strategies for implementing evidence-based treatment and harm reduction interventions for opioid and other substance use disorders. She is interested in the delivery of substance use care in general medical settings as well as developing and studying low-barrier treatment models for substance use disorder. She is the Research Director at the Penn Center for Addiction Medicine and Policy. Dr. Lowenstein also co-chairs the Opioid Use Disorder Workgroup of the Penn Medicine Opioid Task Force and collaborates with partners in Philadelphia to disseminate of best practices for opioid use disorder care.
Dr. Lowenstein received her undergraduate degree at Williams College, a Master’s degree in Biology and Biological Anthropology at the University of Cambridge as a Herchel Smith Fellow, and her medical degree from the University of Pennsylvania Perelman School of Medicine. She completed her residency training in internal medicine at the University of California, San Francisco in the UCSF primary care program and then a fellowship in health policy with the National Clinicians Scholars Program at Penn. She currently practices addiction medicine at the University of Pennsylvania and on Prevention Point Philadelphia’s mobile treatment unit.
Areas of Expertise | Substance Use Disorders, Disadvantaged Populations, Implementation Science, Opioid Epidemic
Clinical Areas | Addiction Medicine, General Internal Medicine
Selected Publications:
Lowenstein M, Perrone J, Xiong RA, Snider CK, O'Donnell N, Hermann D, Rosin R, Dees J, McFadden R, Khatri U, Meisel ZF, Mitra N, Delgado MK. Sustained Implementation of a Multicomponent Strategy to Increase Emergency Department-Initiated Interventions for Opioid Use Disorder. Ann Emerg Med. 2022 Mar;79(3):237-248. doi: 10.1016/j.annemergmed.2021.10.012. Epub 2021 Dec 23. PMID: 34922776; PMCID: PMC8860858.
Lowenstein M, McFadden R, Abdel-Rahman D, Perrone J, Meisel ZF, O'Donnell N, Wood C, Solomon G, Beidas R, Delgado MK. Redesign of Opioid Use Disorder Screening and Treatment in the ED. NEJM Catal Innov Care Deliv. 2022 Jan 1;3(1):10.1056/CAT.21.0297. doi: 10.1056/CAT.21.0297. PMID: 37961066; PMCID: PMC10641724.
Lowenstein M, O'Donnell N, Barnes J, Gallagher K, Gehri G, Pomeroy J, Aronowitz S, Chaiyachati K, Cubbage E, French R, McGinley S, Salerno B, Perrone J. CareConnect: Adapting A Virtual Urgent Care Model to Provide Buprenorphine Transitional Care. NEJM Catal Innov Care Deliv. 2022 Nov 16;3(12):10.1056/CAT.22.0274. doi: 10.1056/CAT22.0274.
Visit Dr. Lowenstein's Google Scholar page to view more publications